| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.015 | 0.8 |